Cellectis S.A. (CLLS) — 6-K Filings

All 6-K filings from Cellectis S.A.. Browse 50 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (50)

6-K Filing — Dec 15, 2025
Cellectis S.A. Files December 2025 6-K Report — Dec 8, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on December 8, 2025, reporting for the month of December 2025. The company, a biopharmaceutical firm based in Paris, France, is
Cellectis S.A. Re-files Exhibit 4.1.3 to Form 6-K — Dec 5, 2025 Risk: low
Cellectis S.A. is re-filing Exhibit 4.1.3 to its Form 6-K, originally submitted on December 5, 2025. The purpose of this re-filing is to correct or update infor
Cellectis S.A. Files Form 6-K — Nov 19, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on November 19, 2025, reporting as a foreign private issuer. The filing indicates that the company is submitting its report unde
Cellectis S.A. Files Form 6-K — Nov 7, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on November 7, 2025, reporting information as a foreign private issuer. The filing incorporates by reference previous registrati
6-K Filing — Nov 3, 2025
6-K Filing — Oct 31, 2025
Cellectis S.A. Files 6-K Regarding BALLI-01 Study — Oct 17, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on October 16, 2025, reporting information related to its BALLI-01 Study. This filing incorporates information into existing reg
Cellectis S.A. Files Form 6-K — Oct 16, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on October 16, 2025, reporting as a foreign private issuer. The company, based in Paris, France, is involved in the biological p
Cellectis S.A. Files Form 6-K — Oct 7, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on October 7, 2025, reporting as a foreign private issuer. The company, incorporated in France with its principal executive offi
Cellectis S.A. Files Form 6-K with SEC — Aug 4, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on August 4, 2025, reporting as a foreign private issuer. The filing indicates that the company will file its annual reports und
Cellectis S.A. Files 6-K Report — Aug 4, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on August 4, 2025, reporting information as of the same date. This filing is a report of a foreign private issuer and is incorpo
Cellectis S.A. Files Routine 6-K Report — Jul 28, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on July 28, 2025, reporting as a foreign private issuer. The company, based in Paris, France, is involved in the biological prod
Cellectis S.A. Files Routine 6-K Report — Jun 26, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on June 26, 2025, reporting as a foreign private issuer. The company, based in Paris, France, is involved in the biological prod
Cellectis S.A. Files 6-K, Reports Board Changes — Jun 26, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on June 26, 2025, reporting changes to its Board of Directors. This filing is incorporated by reference into several of their ex
Cellectis S.A. Files Routine 6-K Report — May 21, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on May 21, 2025, to report information as a foreign private issuer. The filing does not contain specific financial figures or op
Cellectis S.A. Files 6-K for Board Change — May 21, 2025 Risk: low
Cellectis S.A. announced a board change on May 21, 2025. The information regarding this change is incorporated by reference into several of their existing regis
Cellectis S.A. Files 6-K, Confirms 20-F Filing — May 12, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on May 12, 2025, reporting as a foreign private issuer. The company, based in Paris, France, is involved in biological products.
Cellectis Files 6-K, Incorporates Exhibit 99.1 — May 12, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on May 12, 2025, reporting information for its registration statements. The filing incorporates by reference information from Ex
Cellectis S.A. Files Routine 6-K Report — May 6, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on May 6, 2025, to report its activities as a foreign private issuer for the month of May 2025. The company, based in Paris, Fra
Cellectis S.A. Files Routine 6-K Report — Apr 28, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on April 28, 2025, to report information for the month of April 2025. The company, a biopharmaceutical firm based in Paris, Fran
Cellectis Files 6-K, Incorporates Registration Statements — Mar 31, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on March 31, 2025, to incorporate by reference its registration statements on Forms F-3 and S-8. The filing does not contain new
Cellectis S.A. Files Form 6-K for March 2025 — Mar 7, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on March 7, 2025, to report information for the month of March 2025. This filing includes a press release (Exhibit 99.1) which i
Cellectis S.A. Files February 2025 6-K Report — Feb 24, 2025 Risk: low
Cellectis S.A. filed a Form 6-K on February 24, 2025, for the month of February 2025. The filing indicates that Cellectis is a foreign private issuer and files
Cellectis S.A. Files Form 6-K for December 2024 — Dec 10, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on December 10, 2024, to report information for the month of December 2024. This filing includes a press release that will be in
Cellectis Files Form 6-K with SEC — Nov 5, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on November 5, 2024, to report information as a foreign private issuer. The filing indicates that Cellectis is submitting its re
Cellectis Files 6-K, Incorporates Exhibits — Nov 4, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on November 4, 2024, reporting information for its registration statements. The filing incorporates by reference Exhibit 99.1 in
Cellectis S.A. Files 6-K, Confirms 20-F Reporting — Oct 30, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on October 30, 2024, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing provides
Cellectis S.A. Files Routine 6-K Disclosure — Oct 22, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on October 22, 2024, to report its status as a foreign private issuer. The company, based in Paris, France, is required to file
Cellectis S.A. Files September 2024 6-K Report — Sep 3, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on September 3, 2024, to report information for the month of September 2024. The company, a biopharmaceutical firm based in Pari
Cellectis S.A. Files Form 6-K with SEC — Aug 26, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on August 26, 2024, reporting its status as a foreign private issuer. The filing confirms that Cellectis, headquartered in Paris
Cellectis S.A. Files Form 6-K Reporting Status — Aug 7, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on August 7, 2024, reporting its status as a foreign private issuer. The company, based in Paris, France, is involved in biologi
Cellectis Files 6-K, Incorporates Previous Filings — Aug 6, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on August 6, 2024, reporting information as a foreign private issuer. The filing incorporates by reference previous registration
Cellectis S.A. Files Form 6-K — Aug 1, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on August 1, 2024, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing provides b
Cellectis Files Routine 6-K, Confirms 20-F Reporting — Jul 25, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on July 25, 2024, to report its status as a foreign private issuer. The filing confirms that Cellectis, headquartered in Paris,
Cellectis S.A. Shareholders Meet June 28, 2024 — Jun 28, 2024 Risk: low
Cellectis S.A. (the "Company") held its Combined General Meeting of Shareholders on June 28, 2024. The voting results from this meeting are attached as Exhibit
Cellectis S.A. Files 6-K Report — Jun 28, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on June 28, 2024, to report a press release dated June 28, 2024. The filing does not contain specific financial figures or opera
Cellectis S.A. Files Form 6-K, Announces Press Release — Jun 20, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on June 20, 2024, to report a press release dated the same day. The filing does not contain specific financial figures or operat
Cellectis S.A. Files Form 6-K with Press Release — Jun 12, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on June 12, 2024, to report a press release dated June 12, 2024. The filing does not contain specific financial figures or opera
Cellectis S.A. Files Form 6-K — Jun 4, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on June 4, 2024, to report a press release dated June 4, 2024. The filing does not contain specific financial figures or operati
Cellectis S.A. Files Form 6-K with Press Release — May 29, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on May 29, 2024, to report a press release dated May 29, 2024. The filing does not contain specific financial figures or operati
Cellectis S.A. Files Form 6-K — May 28, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on May 28, 2024, reporting a press release dated May 27, 2024. The filing does not contain specific financial figures or operati
Cellectis Files 6-K Report, Incorporates Prior Filings — May 28, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on May 28, 2024, to report information as a foreign private issuer. The filing incorporates by reference previous registration s
Cellectis to Hold Shareholder Meeting June 28 — May 24, 2024 Risk: low
Cellectis S.A. announced its Combined General Meeting of Shareholders will be held on June 28, 2024, at 2:30 p.m. Paris time. The meeting will take place at the
Cellectis S.A. Files 6-K, Incorporates Past Filings — May 6, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on May 6, 2024, to report information for the month of May 2024. This filing incorporates by reference previous registration sta
Cellectis S.A. Files 6-K with Management Update — May 3, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on May 2, 2024, reporting a management update as of April 29, 2024. The filing incorporates information into existing registrati
Cellectis Files 6-K Report with Press Release — Apr 22, 2024 Risk: medium
Cellectis S.A. filed a Form 6-K on April 22, 2024, to report a press release dated April 22, 2024. The filing indicates that Cellectis is a foreign private issu
Cellectis S.A. Files 6-K Report — Apr 10, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on April 10, 2024, reporting a press release dated April 10, 2024. The filing is for a foreign private issuer and indicates that
Cellectis S.A. Files Form 6-K with April 8 Press Release — Apr 8, 2024 Risk: low
Cellectis S.A. filed a Form 6-K on April 8, 2024, reporting information for the month of April 2024. The filing includes a press release dated April 8, 2024, as
Cellectis Draws €15M EIB Credit Tranche for R&D Funding — Jan 16, 2024
Cellectis S.A., a clinical-stage biotechnology company, announced on January 16, 2024, the drawdown of the second tranche of a €15 million credit facility from

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX